[Effect of verospiron and hypothiazide on the indices of electrolyte metabolism in neuroendocrinological obesity].
D000293:Adolescent; D000328:Adult; D004232:Diuretics; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D013148:Spironolactone
Vliianie veroshpirona i gipotiazida na pokazateli élektrolitnogo obmena u bol'nykh s neĭroéndokrinnoĭ formoĭ ozhireniia.